We did not find any significant difference among DC from the three groups of subjects in the expression of two key effectors of the vitamin D response, VDR and CYP24A1, suggesting that DC from MS patients and H controls are similarly equipped to respond to 1,25(OH)2D3. This evidence concerns the gene CYP24A1 and myeloid sarcoma.